Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS Pathogens, 20, 5, S. e1012190-
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2024
- Ereignis
-
Veröffentlichung
- (wer)
-
Public Library of Science (PLoS)
- (wann)
-
2024
- Urheber
-
Karsten, Christina B.
Büttner, Falk
Cajic, Samanta
Nehlmeier, Inga
Roshani, Berit
Klippert, Antonina
Sauermann, Ulrike
Stolte-Leeb, Nicole
Reichl, Udo
Gerardy-Schahn, Rita
Rapp, Erdmann
Stahl-Hennig, Christiane
Pöhlmann, Stefan
- DOI
-
10.1371/journal.ppat.1012190
- URN
-
urn:nbn:de:bvb:384-opus4-1134846
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karsten, Christina B.
- Büttner, Falk
- Cajic, Samanta
- Nehlmeier, Inga
- Roshani, Berit
- Klippert, Antonina
- Sauermann, Ulrike
- Stolte-Leeb, Nicole
- Reichl, Udo
- Gerardy-Schahn, Rita
- Rapp, Erdmann
- Stahl-Hennig, Christiane
- Pöhlmann, Stefan
- Universität Augsburg
- Public Library of Science (PLoS)
Entstanden
- 2024
Ähnliche Objekte (12)
Impact of host cell-specific glycosylation differences on SIV infectivity and mucosal transmission
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization
CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections
Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
Clearly different mechanisms of enhancement of short-lived Nef-mediated viral infectivity between SIV and HIV-1
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
SiV
Güterverzeichnisse Si-V
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
Intramolecular glycosylation
The Neutralization of Egypt.
Impact of host cell-specific glycosylation differences on SIV infectivity and mucosal transmission
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization
CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections
Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
Clearly different mechanisms of enhancement of short-lived Nef-mediated viral infectivity between SIV and HIV-1
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
SiV
Güterverzeichnisse Si-V
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
Intramolecular glycosylation
The Neutralization of Egypt.
Impact of host cell-specific glycosylation differences on SIV infectivity and mucosal transmission
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization
CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections
Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
Clearly different mechanisms of enhancement of short-lived Nef-mediated viral infectivity between SIV and HIV-1
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
SiV
Güterverzeichnisse Si-V
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
Intramolecular glycosylation